Heran Deng

835 total citations
31 papers, 577 citations indexed

About

Heran Deng is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Heran Deng has authored 31 papers receiving a total of 577 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cancer Research, 14 papers in Oncology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Heran Deng's work include Breast Cancer Treatment Studies (13 papers), Breast Lesions and Carcinomas (8 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Heran Deng is often cited by papers focused on Breast Cancer Treatment Studies (13 papers), Breast Lesions and Carcinomas (8 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Heran Deng collaborates with scholars based in China, United States and Macao. Heran Deng's co-authors include Weijuan Jia, Jieqiong Liu, Fengxi Su, Qiang Liu, Shunrong Li, Nanyan Rao, Yaping Yang, Jiannan Wu, Kai Chen and Liang Jin and has published in prestigious journals such as PLoS ONE, Radiology and Clinical Cancer Research.

In The Last Decade

Heran Deng

29 papers receiving 572 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heran Deng China 13 262 216 130 91 81 31 577
Amir Khan Pakistan 13 190 0.7× 144 0.7× 115 0.9× 118 1.3× 87 1.1× 33 530
Samuel G.W. Ow Singapore 12 255 1.0× 128 0.6× 99 0.8× 66 0.7× 54 0.7× 50 426
Shiho Asaka Japan 13 165 0.6× 125 0.6× 155 1.2× 185 2.0× 76 0.9× 56 571
Shinichi Togami Japan 15 137 0.5× 66 0.3× 101 0.8× 85 0.9× 36 0.4× 80 597
Marion Marty France 12 209 0.8× 163 0.8× 217 1.7× 136 1.5× 56 0.7× 40 561
Rula C. Geha United States 10 130 0.5× 184 0.9× 67 0.5× 81 0.9× 103 1.3× 12 451
Yabing Cao China 15 350 1.3× 132 0.6× 191 1.5× 135 1.5× 87 1.1× 52 811
Masato Okigami Japan 12 196 0.7× 147 0.7× 185 1.4× 117 1.3× 24 0.3× 37 569
Vivian Weiß United States 17 305 1.2× 76 0.4× 188 1.4× 83 0.9× 62 0.8× 55 714
Ram Eitan Israel 16 133 0.5× 158 0.7× 150 1.2× 59 0.6× 35 0.4× 73 805

Countries citing papers authored by Heran Deng

Since Specialization
Citations

This map shows the geographic impact of Heran Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heran Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heran Deng more than expected).

Fields of papers citing papers by Heran Deng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heran Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heran Deng. The network helps show where Heran Deng may publish in the future.

Co-authorship network of co-authors of Heran Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Heran Deng. A scholar is included among the top collaborators of Heran Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heran Deng. Heran Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Yunfang, Xueyuan Jia, Heran Deng, et al.. (2024). Deciphering the role of apoptosis signature on the immune dynamics and therapeutic prognosis in breast cancer: Implication for immunotherapy. Frontiers in Genetics. 15. 1332935–1332935.
2.
3.
Liu, Jieqiong, et al.. (2023). Impact of Atypical Hyperplasia at Surgical Margins on breast cancer outcomes in patients treated with neoadjuvant chemotherapy. Frontiers in Oncology. 13. 1202689–1202689. 1 indexed citations
4.
5.
6.
Li, Qian, Yifan Wang, Weijuan Jia, et al.. (2019). Low-Dose Anti-Angiogenic Therapy Sensitizes Breast Cancer to PD-1 Blockade. Clinical Cancer Research. 26(7). 1712–1724. 116 indexed citations
7.
Wang, Yan, Yaping Yang, Zhengbo Chen, et al.. (2019). Development and validation of a novel nomogram for predicting distant metastasis-free survival among breast cancer patients. Annals of Translational Medicine. 7(20). 537–537. 16 indexed citations
8.
Li, Jingjing, Jing Zhang, Liang Jin, Heran Deng, & Jiannan Wu. (2018). Silencinglnc-ASAH2B-2Inhibits Breast Cancer Cell Growthviathe mTOR Pathway. Anticancer Research. 38(6). 3427–3434. 9 indexed citations
9.
10.
Zhang, Mingxia, Jiannan Wu, Kai Mao, et al.. (2017). Role of transforming growth factor-β1 in triple negative breast cancer patients. International Journal of Surgery. 45. 72–76. 20 indexed citations
11.
Mao, Kai, Yaping Yang, Wei Wu, et al.. (2017). Risk of second breast cancers after lobular carcinoma in situ according to hormone receptor status. PLoS ONE. 12(5). e0176417–e0176417. 6 indexed citations
12.
13.
Liu, Jieqiong, Hui‐Shan Guo, Kai Mao, et al.. (2016). Impact of estrogen receptor-β expression on breast cancer prognosis: a meta-analysis. Breast Cancer Research and Treatment. 156(1). 149–162. 16 indexed citations
14.
15.
Wu, Jiannan, Shunrong Li, Weijuan Jia, et al.. (2015). Reduced Let-7a Is Associated with Chemoresistance in Primary Breast Cancer. PLoS ONE. 10(7). e0133643–e0133643. 34 indexed citations
16.
Jia, Haixia, Weijuan Jia, Yaping Yang, et al.. (2014). HER-2 positive breast cancer is associated with an increased risk of positive cavity margins after initial lumpectomy. World Journal of Surgical Oncology. 12(1). 289–289. 20 indexed citations
17.
Li, Shunrong, Jieqiong Liu, Yaping Yang, et al.. (2014). Impact of atypical hyperplasia at margins of breast-conserving surgery on the recurrence of breast cancer. Journal of Cancer Research and Clinical Oncology. 140(4). 599–605. 10 indexed citations
18.
Zhao, Jianli, Jieqiong Liu, Kai Chen, et al.. (2014). What lies behind chemotherapy-induced amenorrhea for breast cancer patients: a meta-analysis. Breast Cancer Research and Treatment. 145(1). 113–128. 74 indexed citations
19.
Chen, Kai, Xiaolan Zhang, Heran Deng, et al.. (2014). Clinical Predictive Models for Chemotherapy-Induced Febrile Neutropenia in Breast Cancer Patients: A Validation Study. PLoS ONE. 9(6). e96413–e96413. 14 indexed citations
20.
Liu, Jieqiong, Heran Deng, Weijuan Jia, et al.. (2012). Comparison of ER/PR and HER2 statuses in primary and paired liver metastatic sites of breast carcinoma in patients with or without treatment. Journal of Cancer Research and Clinical Oncology. 138(5). 837–842. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amir Khan Breakdown of academic impact, for papers by Samuel G.W. Ow Breakdown of academic impact, for papers by Shiho Asaka Breakdown of academic impact, for papers by Shinichi Togami Breakdown of academic impact, for papers by Marion Marty Breakdown of academic impact, for papers by Rula C. Geha Breakdown of academic impact, for papers by Yabing Cao Breakdown of academic impact, for papers by Masato Okigami Breakdown of academic impact, for papers by Vivian Weiß Breakdown of academic impact, for papers by Ram Eitan
Rankless by CCL
2026